Ann: First patent granted for Deoxymab-nanoparticles, page-30

Sorry I was not clear. I meant a big pharma could buy 10% or 20% new shares in Patrys which would get us $14 million or $28 million cash respectively. So they own 20% of Patrys and reap the millions or billions if our cure is approved. We still keep our holdings and reap 10 times the current SP when the big pharma buys a stake. The company will be cashed up and will not need to make any cheap rights placements. This happened with Mesoblast 10 years ago and the market cap went to $500 million when the big pharma took a stake in it. MSB still don’t have an approved product though.

Remember out product crosses the brain barrier and nothing else does, it also produces antigens which latch on the cancer cells and kills them and stops them from replicating. Our time has come.